Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nonprecipitating asymmetric antibodies.

× No keyword cloud information.

17 in total

1. Asymmetric non-precipitating antibodies in commercial hyperimmune gamma-globulin for therapeutic use.

Authors: S Miranda; I Malan Borel; J Dokmetjian; R A Margni; R A Binaghi
Journal: Immunology Date: 1992-04 Impact factor: 7.397

Review 2. Antinuclear antibody determination methods.

Authors: D G Williams; P J Charles; M Field; S M Chua; R N Maini
Journal: Clin Rheumatol Date: 1990-03 Impact factor: 2.980

3. Asymmetric Fab glycosylation in guinea-pig IgG1 and IgG2.

Authors: I Malan Borel; T Gentile; J Angelucci; R A Margni; R A Binaghi
Journal: Immunology Date: 1990-07 Impact factor: 7.397

4. The S228P mutation prevents in vivo and in vitro IgG4 Fab-arm exchange as demonstrated using a combination of novel quantitative immunoassays and physiological matrix preparation.

Authors: John-Paul Silva; Olivia Vetterlein; Joby Jose; Shirley Peters; Hishani Kirby
Journal: J Biol Chem Date: 2015-01-07 Impact factor: 5.157

5. Heterogeneity of the Ro/SSA antigen. Different molecular forms in lymphocytes and red blood cells.

Authors: M D Rader; C O'Brien; Y S Liu; J B Harley; M Reichlin
Journal: J Clin Invest Date: 1989-04 Impact factor: 14.808

6. Changes in oligosaccharide chains of autoantibodies to GRP78 expressed during progression of malignant melanoma stimulate melanoma cell growth and survival.

Authors: Maria A Selim; James L Burchette; Edith V Bowers; Gustaaf G de Ridder; Lihong Mo; Salvatore V Pizzo; Mario Gonzalez-Gronow
Journal: Melanoma Res Date: 2011-08 Impact factor: 3.599

10. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.

Authors: Inga Koneczny; Judith Cossins; Patrick Waters; David Beeson; Angela Vincent
Journal: PLoS One Date: 2013-11-07 Impact factor: 3.240

Nonprecipitating asymmetric antibodies.